Aevus Precision Rx
ML powered drug selection platform for treating Type 2 Diabetes
- Stage Product In Development
- Industry Healthcare Services
- Location Norman, OK, USA
- Currency USD
- Founded August 2019
- Employees 5
- Incorporation Type C-corp
- Website aevus.ai
Company Summary
Aevus is engineering a ML -powered Prescription Guidance Platform - Aevus Precision Rx for PCPs/NPs/PAs to tailor prescriptions for Type 2 diabetes (T2D) patients. In doing so, Aevus intends to improve T2D drug outcomes, reduce medication switching and lower treatment costs. Once implemented within the clinical workflow, our users will order prescription guidance from our platform using a sequence of mouse-clicks on their EHR system.
Team
-
Co-Founder, COO -
Co-Founder, CEO -
Co-Founder, Head of Data Science
Previous Investors
-
Piyush PatelUnconfirmed
i2EUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.